Tirzepatide dosing for weight loss in units depends on the concentration of your specific product. Branded Zepbound and Mounjaro pens deliver set milligram doses without any unit math, but compounded versions typically require drawing a measured number of units from a vial using an insulin syringe. Getting the conversion right is critical for safety and results.
Why Some Tirzepatide Is Dosed in Units
Brand-name tirzepatide (Zepbound and Mounjaro) comes in single-use pens preloaded with 2.5, 5, 7.5, 10, 12.5, or 15 mg per injection. Compounded tirzepatide, dispensed by certain pharmacies during FDA-declared shortages, is usually sold as a multi-dose vial. Patients draw the dose into a U-100 insulin syringe — the same kind used for insulin — and measure by units rather than milligrams.
The FDA has warned about dosing errors with compounded GLP-1 drugs, including several hospitalizations traced to unit conversion mistakes.
Converting Milligrams to Units
On a U-100 insulin syringe, 100 units equals 1 mL. So the formula is:
Units = (mg dose ÷ concentration in mg/mL) × 100
Common compounded concentrations include 5 mg/mL and 10 mg/mL. Here is how the standard milligram steps translate:
| Milligram Dose | Units (5 mg/mL vial) | Units (10 mg/mL vial) | Volume (mL) |
|---|---|---|---|
| 2.5 mg | 50 units | 25 units | 0.25-0.50 mL |
| 5 mg | 100 units | 50 units | 0.50-1.00 mL |
| 7.5 mg | 150 units (2 syringes) | 75 units | 0.75-1.50 mL |
| 10 mg | 200 units (2 syringes) | 100 units | 1.00-2.00 mL |
| 12.5 mg | Not typical | 125 units | 1.25 mL |
| 15 mg | Not typical | 150 units | 1.50 mL |
Always verify your vial’s concentration — the table above is an illustration, not a substitute for your pharmacy’s directions.
Standard Titration Schedule
The FDA-approved titration from the Zepbound prescribing information is the same framework used for compounded doses:
- Weeks 1-4: 2.5 mg weekly (starting dose — do not expect weight loss yet)
- Weeks 5-8: 5 mg weekly (first maintenance dose option)
- Weeks 9-12: 7.5 mg weekly
- Weeks 13-16: 10 mg weekly (second maintenance dose option)
- Weeks 17-20: 12.5 mg weekly
- Week 21+: 15 mg weekly (maximum)
Stay at a given step for at least four weeks before moving up. If side effects are strong, stay longer or drop back one step.
Injection Technique Basics
- Inject subcutaneously in the abdomen (two inches from the navel), thigh, or upper arm
- Rotate sites each week to prevent irritation
- Allow the vial to reach room temperature about 15 to 20 minutes before drawing
- Use a new syringe and needle for every dose
- Pinch the skin gently, insert at 45 to 90 degrees, push slowly
- Dispose of sharps in an FDA-approved container
Common Side Effects at Each Dose
Side effects usually increase with dose. The 2.5 mg starting dose is meant mostly to build tolerance — expect meaningful weight changes once you reach 5 mg or above. Nausea affects roughly 25 to 30 percent of patients, especially in the first two weeks of a new step. Diarrhea, constipation, and fatigue are also common. For a deep dive into what to expect, see our guide on prediabetes and obesity treatments.
Safety Red Flags for Compounded Dosing
The FDA flagged the following common mistakes with compounded tirzepatide:
- Mistaking milliliters for units (a 10x overdose)
- Using the wrong syringe — U-100 insulin syringes are needed, not tuberculin syringes
- Storing vials improperly (tirzepatide must stay refrigerated)
- Drawing from a vial past its beyond-use date
- Escalating doses too quickly based on videos on social media
Always contact your prescriber if the math feels unclear. Getting the wrong dose is the leading cause of ER visits in this drug class. For context on how tirzepatide compares with other options, see our overview of prediabetes basics.
When to Stop and Call Your Doctor
- Severe, persistent abdominal pain
- Uncontrolled vomiting for more than 24 hours
- Signs of dehydration: dizziness, dark urine, rapid heart rate
- Yellowing of skin or eyes
- Lump or swelling in the neck
- Severe allergic reactions — rash, throat tightness, trouble breathing
The Bottom Line
Tirzepatide dosing in units is straightforward once you know your vial’s concentration, but the math is unforgiving. The same number of units can be one-tenth or ten times the intended dose depending on the solution. Always double-check with your pharmacy, follow the four-week titration schedule, and call your doctor about any concerning symptoms. When in doubt, branded Zepbound and Mounjaro pens eliminate the conversion entirely.
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor before starting, stopping, or changing any medication.
